TLDR
Market Recap: March 4, 2026
On March 4, Indian equities extended their selloff as Middle East escalation pushed crude higher, stoking India inflation fears and pressuring the rupee, while domestic buyers tried to cushion the fall. Sensex closed at 79,116.19 (down 1,122.66, -1.40%) and Nifty 50 at 24,480.50 (down 385.20, -1.55%), with broader risk-off visible as Nifty Midcap 100 (-2.2%) and Nifty Smallcap 100 (-2.1%) underperformed. Volatility surged with India VIX at 21.14 (up 23.41%), underscoring elevated hedging demand into the close.
Key Drivers :
Crude shock rewrites the inflation playbook: Brent jumped to $83.95 as the conflict escalated, reviving inflation risk and complicating the near-term rate-cut narrative for India.
Foreign selling, domestic absorption: FIIs were net sellers (₹8,752.65 cr) while DIIs were net buyers (₹12,068.17 cr), keeping the tape orderly even as breadth stayed weak.
Fear bid returns in size: India VIX spiked to 21.14, its highest close since May 2025, while smallcaps and midcaps took the brunt of de-risking.
Today’s Top Stories:
JSW Infra: Drone debris damaged a Fujairah tank; no injuries, insurance in place; stock slipped around 2% to 3% as overseas-risk optics worsened.
L&T: Middle East execution risk dominated, dragging the stock to a one-month low with a sharp intraday drop amid escalation jitters.
Cipla: A Kemwell biologics JV (60:40) kicked off a capability build; shares stayed weak in early trade as markets remained risk-off.
Natco: US launch of generic Pomalidomide strengthened its oncology book; shares popped over 2% after the announcement.
PNGS Reva: Listed at a discount but ended near 7% above issue, with IPO proceeds tied to a 15-store expansion plan by FY28.
Market Snapshot
CNBC
Nifty 50 Index Heatmap
Trading View
Top Gainers & Losers
Trading View
TOP STORIES
1. JSW Infra: Fujairah Tank Damaged by Drone Debris
Gemini-2.5
Incident: Drone debris damaged 1 of 15 tanks at Fujairah Liquid Terminal; emergency protocols activated, no injuries reported.
Operational read: Remaining tanks secured; company flagged insurance cover and technical assessment for restoration.
Tape impact: Stock slipped as markets repriced overseas-asset geopolitical optics.
Drone debris damaged a JSW Infra Fujairah tank. Market read?
2. L&T Hits a One-Month Low as Middle East Exposure Gets Cut
Gemini-2.5
Risk trigger: L&T fell over 7% intraday to a one-month low amid escalation fears, heightening Middle East-linked execution risk.
Why it matters: The region contributes roughly a third of inflows and revenue, making L&T a proxy for disruption risk.
Market impact: The stock-led index drags as investors reduce global-exposure beta.
L&T selloff on Middle East risk is:
3. Cipla-Kemwell: 60:40 Biologics JV Kicks Off Capability Build
Gemini-2.5
Deal: Cipla signed a 60:40 JV with Kemwell to develop, license, manufacture, and commercialize biologics.
Capital: Partners plan to make an initial investment of up to ₹10 crore in the JV.
Strategic angle: Builds end-to-end biologics access via Kemwell’s CDMO capabilities and facilities.
Cipla-Kemwell biologics JV is:
4. Natco Launches Generic Pomalidomide in the US
Gemini-2.5
Launch: Natco announced the US launch of Pomalidomide Capsules with partner Breckenridge.
Why it matters: Adds to Natco’s oncology and complex-generic playbook in a high-value category.
Tape impact: Shares rose over 2% in early trade after the announcement.
Natco’s Pomalidomide launch impact:
5. PNGS Reva Lists Weak, Then Closes Strong
Gemini-2.5
Listing: Opened at a discount on BSE and NSE versus the issue price, reflecting cautious primary sentiment.
Twist: Shares later closed higher on debut, showing dip buying into the story even as benchmarks fell.
What to watch: Post-listing stability now becomes the real sentiment check.
Discount open, strong close means:
GYAANI HOT TAKES
Disclaimer:
The IndiaStox Research Hackathon is intended for educational and community engagement purposes only. Submissions do not constitute investment advice, nor should they be construed as recommendations to buy or sell any securities.
By participating in the IndiaStox Research Hackathon and submitting content, you grant IndiaStox a worldwide, royalty-free, perpetual, and irrevocable license to use, reproduce, modify, publish, distribute, and display your submission, whether in whole or in part, across its digital platforms and in promotional materials. This license extends to both commercial and non-commercial purposes, including content seeding, editorial use, and advertising.
By submitting your work, you confirm that it is your original creation and that you have the right to grant the above license.
